Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel C Adelman

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 16, 2022
Participant characteristics and safety outcomes of peanut oral immunotherapy in the RAMSES and ARC011 trialsChristina Ciaccio, Alan B Goldsobel, Aikaterini Anagnostou, et al.
The Journal of Allergy and Clinical Immunology|February 11, 2021
Using data from food challenges to inform management of consumers with food allergy: A systematic review with individual participant data meta-analysisNandinee Patel, Daniel C Adelman, Katherine Anagnostou, et al.
The Lancet. Child & Adolescent Health|July 24, 2020
Efficacy and safety of oral immunotherapy with AR101 in European children with a peanut allergy (ARTEMIS): a multicentre, double-blind, randomised, placebo-controlled phase 3 trialJonathan O'B Hourihane, Kirsten Beyer, Allyah Abbas, et al.
The Journal of Allergy and Clinical Immunology|April 1, 2023
Distinct trajectories distinguish antigen-specific T cells in peanut-allergic individuals undergoing oral immunotherapyJustine Calise, Hannah DeBerg, Nahir Garabatos, et al.
Allergy|December 14, 2024
Dupilumab as an Adjunct to Oral Immunotherapy in Pediatric Patients With Peanut AllergyR Sharon Chinthrajah, Sayantani B Sindher, Kari C Nadeau, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 28, 2020
Continuous and Daily Oral Immunotherapy for Peanut Allergy: Results from a 2-Year Open-Label Follow-On StudyBrian P Vickery, Andrea Vereda, Caroline Nilsson, et al.
The New England Journal of Medicine|November 20, 2018
AR101 Oral Immunotherapy for Peanut Allergy, Brian P Vickery, Andrea Vereda, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 16, 2022
Participant characteristics and safety outcomes of peanut oral immunotherapy in the RAMSES and ARC011 trialsChristina Ciaccio, Alan B Goldsobel, Aikaterini Anagnostou, et al.
The Journal of Allergy and Clinical Immunology|February 11, 2021
Using data from food challenges to inform management of consumers with food allergy: A systematic review with individual participant data meta-analysisNandinee Patel, Daniel C Adelman, Katherine Anagnostou, et al.
The Lancet. Child & Adolescent Health|July 24, 2020
Efficacy and safety of oral immunotherapy with AR101 in European children with a peanut allergy (ARTEMIS): a multicentre, double-blind, randomised, placebo-controlled phase 3 trialJonathan O'B Hourihane, Kirsten Beyer, Allyah Abbas, et al.
The Journal of Allergy and Clinical Immunology|April 1, 2023
Distinct trajectories distinguish antigen-specific T cells in peanut-allergic individuals undergoing oral immunotherapyJustine Calise, Hannah DeBerg, Nahir Garabatos, et al.
Allergy|December 14, 2024
Dupilumab as an Adjunct to Oral Immunotherapy in Pediatric Patients With Peanut AllergyR Sharon Chinthrajah, Sayantani B Sindher, Kari C Nadeau, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 28, 2020
Continuous and Daily Oral Immunotherapy for Peanut Allergy: Results from a 2-Year Open-Label Follow-On StudyBrian P Vickery, Andrea Vereda, Caroline Nilsson, et al.
The New England Journal of Medicine|November 20, 2018
AR101 Oral Immunotherapy for Peanut Allergy, Brian P Vickery, Andrea Vereda, et al.
Pageof 3